Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa
about
HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care?The effect of tuberculosis treatment at combination antiretroviral therapy initiation on subsequent mortality: a systematic review and meta-analysisThe effect of tuberculosis treatment on virologic and CD4+ cell count response to combination antiretroviral therapy: a systematic reviewPrevalence, trend and risk factors for antiretroviral therapy discontinuation among HIV-infected adults in Ethiopia in 2003-2015Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.Inpatient mortality of HIV-infected adults in sub-Saharan Africa and possible interventions: a mixed methods reviewA randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trial.Trends in and determinants of loss to follow up and early mortality in a rapid expansion of the antiretroviral treatment program in Vietnam: findings from 13 outpatient clinicsCommunity-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.The association between self-reported stigma and loss-to-follow up in treatment eligible HIV positive adults in rural Kwazulu-Natal, South Africa.Factors Associated with Early Mortality in HIV-Positive Men and Women Investigated for Tuberculosis at Ethiopian Health Centers.Nutritional Status and Other Baseline Predictors of Mortality among HIV-Infected Children Initiating Antiretroviral Therapy in Tanzania.Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa.Facilitating point-of-care detection/suspicion of early TB disease to enable early treatment access, while awaiting more definitive microbiologic diagnosisSizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South AfricaReducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa.Unrecognised tuberculosis at antiretroviral therapy initiation is associated with lower CD4+ T cell recovery.Tuberculosis and non-tuberculous mycobacteria among HIV-infected individuals in Ghana.Long-term Outcome of Antiretroviral Treatment in Patients With and Without Concomitant Tuberculosis Receiving Health Center-Based Care-Results From a Prospective Cohort Study.Scaling up implementation of ART: Organizational culture and early mortality of patients initiated on ART in Nairobi, Kenya.The effectiveness and cost-effectiveness of community-based support for adolescents receiving antiretroviral treatment: an operational research study in South Africa.Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America.Reasons and predictors for antiretroviral therapy change among HIV-infected adults at South West Ethiopia.
P2860
Q27010874-4E1F1AAA-40EA-4B70-A5FA-6D0912F8A14EQ27014121-2ECBFFD2-4801-479F-80A4-0EC7339FC6A4Q30658709-429AFE40-95E2-4362-82AF-0FAD4AE7B96FQ33807108-284D5EDF-D22D-44C0-9CC4-126157339B64Q34413586-455A59E0-41D7-45FB-8BB6-ED859EDB7F55Q34589601-84CBBBB3-2C64-445A-B042-AD907C43287AQ34694867-011C7A23-08C3-49C1-A22F-ACE397510493Q34968268-8900C491-F3CC-48C1-BC9B-C9A8159E5414Q34996955-1A318C16-08BE-4ECA-83D7-C2D667D26FD8Q35072895-289E690F-0F7C-45AD-8855-5ADACDEFFE89Q35106038-8C50D69A-5831-4AAC-B480-1E8BFBCB2202Q36043944-B5B70910-5954-4035-8AC7-5D77737C6AFDQ36232910-EC5A0502-4DE4-42D4-9749-0C83E3C340EDQ36544931-7BA61C8E-421F-476A-B11C-72299B77D853Q36731598-68DDD0F5-8A8F-487D-BD43-DEA114795243Q37262243-AF4715BA-074F-49D7-92E1-3C59163C872EQ37285167-B73FD631-6A72-42AA-934E-B1ED1D827A74Q37659139-EB51AAFE-67F4-471B-8E98-E2FC7EEEA9B5Q38866845-6E9320DF-1D90-4CCC-A729-FF32EF5D2818Q39627454-AB5C7BD6-0770-47CC-BFDD-E7846FD135A5Q46634665-342E0284-8C58-42F6-9E40-1C08CBF2867AQ47223924-CEB97845-595C-429E-B819-A291A812D9E4Q51410002-93DC510D-C339-4251-9EE1-075F2B23CB04Q53821839-420681D8-FADF-4AD9-8D13-EF0AD8621DCDQ55257500-A3B301E9-F1BF-483C-BC70-2928082302E4
P2860
Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Loss to follow-up and mortalit ...... iation in Durban, South Africa
@ast
Loss to follow-up and mortalit ...... iation in Durban, South Africa
@en
type
label
Loss to follow-up and mortalit ...... iation in Durban, South Africa
@ast
Loss to follow-up and mortalit ...... iation in Durban, South Africa
@en
prefLabel
Loss to follow-up and mortalit ...... iation in Durban, South Africa
@ast
Loss to follow-up and mortalit ...... iation in Durban, South Africa
@en
P2093
P2860
P50
P1476
Loss to follow-up and mortalit ...... iation in Durban, South Africa
@en
P2093
Bingxia Wang
Matilda Mazibuko
Senica Chetty
Zhigang Lu
P2860
P356
10.1097/QAI.0B013E31823D3ABA
P407
P577
2012-01-01T00:00:00Z